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Summary
Current models to estimate radiation risk use the Life Span Study (LSS) cohort that received high doses and high dose rates of radiation.
Transferring risks from these high dose rates to the low doses and dose rates received by astronauts in space is a source of uncertainty in our
risk calculations. The solid cancer models recommended by BEIR VII [1], UNSCEAR [2], and Preston et al [3] is fitted adequately by a linear
dose response model, which implies that low doses and dose rates would be estimated the same as high doses and dose rates. However
animal and cell experiments imply there should be curvature in the dose response curve for tumor induction. Furthermore animal experiments
that directly compare acute to chronic exposures show lower increases in tumor induction than acute exposures. A dose and dose rate
effectiveness factor (DDREF) has been estimated and applied to transfer risks from the high doses and dose rates of the LSS cohort to low
doses and dose rates such as frommissions in space.
The BEIR VII committee [1] combined DDREF estimates using the LSS cohort and animal experiments using Bayesian methods for their
recommendation for a DDREF value of 1.5 with uncertainty. We reexamined the animal data considered by BEIR VII and included more animal
data and human chromosome aberration data to improve the estimate for DDREF. Several experiments chosen by BEIR VII were deemed
inappropriate for application to human risk models of solid cancer risk. Animal tumor experiments performed by Ullrich et al [4], Alpen et al [5],
and Grahn et al [6] were analyzed to estimate the DDREF. Human chromosome aberration experiments performed on a sample of astronauts
within NASA were also available to estimate the DDREF. The LSS cohort results reported by BEIR VII were combined with the new
radiobiology results using Bayesian methods.
Reexamine the animal tumor data considered by BEIR
We reanalyzed the animal tumor experiments performed by Ullreich et al [4] and added the tumor data published by Alpen et al [5] for the
Pituitary gland. Only doses below 2Gy were included in the analysis. We analyzed all the data jointly assuming that the curvature, θ, was the
same for all tumor types. The model allows each type of cancer and type of mouse to have its own baseline cancer risk, linear increase, and
quadratic increase in cancer risk. Unlike the Beir VII analysis, we allowed the chronic data to contribute to the estimation of the linear term in
themodel. The curvature is estimated instead of the quadratic term as follows:
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where i is an indicator for each type of cancer and mouse and IሺDoseacuteሻ is the indicator function for acute doses. Themodel assumes risks are
normally distributed with variances that are proportional to the reciprocal of the squared standard errors. We assumed that the DDREF has a
log‐normal distribution withmean lnሺ1൅θሻ and error determined using the delta method.
Incorporate the Argonne National Lab animal data
Grahn et al [6] published analyses of survival data for mice exposed acutely and chronically which included histological tumor information for
the causes of death. Linear dose response, α values were published for both the acute and chronic data. The data were divided into individual
epithelial cancers which included lung, liver, Harderian gland, and glandular/reproductive tumors. The data were further divided by gender and
into two intervals of ages, 600‐799 days and 800‐899 days. For each cancer type, gender and age interval, the DDREF can be estimated using
the published α values as follows:
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If we assume that the DDREF is log‐normal, we can estimate the variance of the natural log of the DDREF as:
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The natural logarithm transformed DDREF’s can be aggregated across the different cancer types, genders, and age intervals using the
generalized inverse variance method.
Incorporate the Astronaut chromosome aberration data
The chromosome aberration data were combined similarly to the animal cancer risk data for 28 individual astronauts. Translocations were
used as the measure of chromosome damage using 3‐color FiSH [7]. Each astronaut in the model had their own estimate for initial prevalence
and linear increase. The combined curvature, θ, in the linear quadratic fit for astronaut translocation could be determined as:
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Only doses below 2.5 Gy were included in the analysis. The model assumes risks are normally distributed with variances that are proportional
to the reciprocal of the squared standard errors. We assumed that the DDREF had a log‐normal distribution with mean lnሺ1൅θሻ and error
determined using the delta method.
Estimate the likelihood of the LSS Cohort using BEIR VII reported values
A log‐normal distribution was fit using the reported LSS DDREF and confidence limit.
Combine the Distributions using Bayesian methods
Each prior distribution and likelihood is assumed to be log‐normal. Using a conjugate prior determined by the log‐normal distributions,
combining these distributions results in a posterior with a student’s t distribution on the log scale.
Results
Results are based on a Bayesian statistical analysis of DDREF values. The
probability density labeled “Astronaut CA” expresses the belief about DDREF
deduced from human chromosome aberration experiments performed on a
sample of astronauts within NASA. The probability density labeled “Animal
Cancer Risks” expresses the belief about DDREF deduced from animal tumor
experiments performed by Ullrich [4] and Alpen [5]. The probability density
labeled “Argonne Lab Animals” expresses the belief about DDREF deduced
from animal tumor experiments performed by Grahn [6]. The probability
density labeled “LSS cohort” expresses the belief about DDREF approximated
from the BEIR VII reported LSS data [1]. The “combined” density is the
Bayesian posterior obtained by updating the radiobiological densities to
account for the information from the LSS data.
Estimated DDREF
LSS cohort 1.3 (0.8, 2.6)
Animal Cancer Risks 1.84 (1.49, 2.27)
Argonne Lab Animals 1.99 (1.52, 2.61)
Astronaut CA 2.65 (2.24, 3.13)
Posterior: BEIR VII 1.5 (1.1, 2.6)
Posterior: LSS + animal 1.7 (1.0, 2.9)
Posterior: all 1.9 (1.2, 3.0)
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